SPG11 and hereditary spastic paraplegia: Furthermore, data were available on the prevalence of SPG11 from seven studies in six countries [1, 6, 22, 23, 29, 32, 33], where the mutation frequency of SPG11 in HSP patients ranged from 2% in Italy-Pisa/Tuscany [23] to 11% in China [30].